Recent Finacing
Recent Raise
Correlia Biosystems develops a miniaturized, automated lab-on-a-chip immunoassay platform that accelerates ELISA testing using nanomaterials and automation to run rapid assays on <1 microliter samples.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Correlia Biosystems.
